SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-24-013736
Filing Date
2024-04-29
Accepted
2024-04-29 16:55:37
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A pirs20231231_10ka.htm   iXBRL 10-K/A 530463
2 EXHIBIT 31.3 ex_652411.htm EX-31.3 2998
3 EXHIBIT 31.4 ex_652412.htm EX-31.4 3094
  Complete submission text file 0001437749-24-013736.txt   805032

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pirs-20231231.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20231231_def.xml EX-101.DEF 17405
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20231231_lab.xml EX-101.LAB 23725
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20231231_pre.xml EX-101.PRE 18445
19 EXTRACTED XBRL INSTANCE DOCUMENT pirs20231231_10ka_htm.xml XML 7883
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37471 | Film No.: 24892177
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)